The novel association of the chemokine CCL22 with abdominal aortic aneurysm

American Journal of Pathology

Volumn 176, Issue 5, 2010, Pages 2098-2106

  Golledge, Jonathan ^a   Clancy, Paula ^a   Moran, Corey ^a   Biros, Erik ^a   Rush, Catherine ^a   Walker, Philip ^b   Norman, Paul ^c  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE;

ABDOMINAL AORTA ANEURYSM; ARTERY DILATATION; ARTICLE; BLOOD VESSEL BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; UPREGULATION;

EID: 77952040848     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090416     Document Type: Article

References (39)

1. Kent KC, Zwolak RM, Jaff MR, Hollenbeck ST, Thompson RW, Schermerhorn ML, Sicard GA, Riles TS, Cronenwett JL, Society for Vascular Surgery, American Association of Vascular Surgery, Society for Vascular Medicine and Biology. Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg 2004,39:267-269
2. Golledge J, Muller J, Daugherty A, Norman P: Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26:2605-2613
3. Shimizu K, Mitchell RN, Libby P: Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:987-994
4. O'Shea JJ, Murray PJ: Cytokine signaling modules in inflammatory responses. Immunity 2008, 28:477-487
5. Hansson GK, Robertson AK, Söderberg-Nauclér C: Inflammation and atherosclerosis. Annu Rev Pathol 2006, 1:297-329
6. Treska V, Topolcan O, Pecen L: Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 2000, 38:1161-1164 (Pubitemid 32040864)
7. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjälä H, Airaksinen J, Leinonen M, Saikku P, Juvonen T: Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997, 17:2843-2847
8. Dawson J, Cockerill GW, Choke E, Belli AM, Loftus I, Thompson MM: Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg 2007, 45:350-356 (Pubitemid 46149985)
9. Feng L, Matsumoto C, Schwartz A, Schmidt AM, Stern DM, Pile-Spellman J: Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis. Diabetes Care 2005, 28:379-384 (Pubitemid 40170943)
10. Neri Serneri GG, Boddi M, Modesti PA, Coppo M, Cecioni I, Toscano T, Papa ML, Bandinelli M, Lisi GF, Chiavarelli M: Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. Circ Res 2004, 94:1630-1637
11. Rehring TF, Stolcpart RS, Hollis HW Jr, Society for Vascular Surgery: Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons. J Vasc Surg 2008, 47:1108-1115
12. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K: Cohort Profile: the Health In Men Study (HIMS). Int J Epidemiol 2009, 38:48-52
13. Golledge J, Jayalath R, Oliver L, Parr A, Schurgers L, Clancy P: Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 2008, 197:428-434 (Pubitemid 351273264)
14. Moran CS, McCann M, Karan M, Norman P, Ketheesan N, Golledge J: Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 2005, 111:3119-3125 (Pubitemid 40847790)
15. Storey JD, Tibshirani R: Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 2003, 224:149-157
16. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B, 1995, 57:289-300
17. Lindeman JH, Abdul-Hussien H, Schaapherder AF, Van Bockel JH, Von der Thüsen JH, Roelen DL, Kleemann R: Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin Sci (Lond) 2008, 114:687-697
18. Treska V, Kocova J, Boudova L, Neprasova P, Topolcan O, Pecen L, Tonar Z: Inflammation in the wall of the abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cyto Cell Mol Ther 2002, 7:91-97 (Pubitemid 36850423)
19. Middleton RK, Lloyd GM, Bown MJ, Cooper NJ, London NJ, Sayers RD: The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 2007, 45:574-580
20. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, Haines GK, Burdick MD, Strieter RM: Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993, 142:1423-1431
21. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994, 90:II224 -II227 (Pubitemid 24349275)
22. Hamano K, Li TS, Takahashi M, Kobayashi T, Shirasawa B, Ito H, Zempo N: Enhanced tumor necrosis factor- alpha expression in small sized abdominal aortic aneurysms. World J Surg 2003, 27:476-480 (Pubitemid 36920125)
23. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, Baxter BT: Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 2001, 101:152-156 (Pubitemid 34044554)
24. Pearce WH, Sweis I, Yao JS, McCarthy WJ, Koch AE: Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J Vasc Surg 1992, 16:784-789
25. Cheuk BL, Cheng SW: Differential secretion of prostaglandin E(2), thromboxane A(2) and interleukin-6 in intact and ruptured abdominal aortic aneurysms. Int J Mol Med 2007, 20:391-395
26. Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, Karmeli R: Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 2000, 20:462-465
27. Reilly JM, Miralles M, Wester WN, Sicard GA: Differential expression of prostaglandin E2 and interleukin-6 in occlusive and aneurysmal aortic disease. Surgery 1999, 126:624-627
28. Szekanecz Z, Shah MR, Pearce WH, Koch AE: Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions 1994, 42:159-162
29. Holmes DR, Wester W, Thompson RW, Reilly JM: Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Surg 1997, 25:810-815
30. Satoh H, Nakamura M, Satoh M, Nakajima T, Izumoto H, Maesawa C, Kawazoe K, Masuda T, Hiramori K: Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm. Clin Sci (Lond) 2004, 106:301-306
31. Galle C, Schandené L, Stordeur P, Peignois Y, Ferreira J, Wautrecht JC, Dereume JP, Goldman M: Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol 2005, 142:519-527
32. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN: Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. J Clin Invest 2004, 114:300-308
33. Xiong W, Zhao Y, Prall A, Greiner TC, Baxter BT: Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 2004, 172:2607-2612
34. Hata H, Yoshimoto T, Hayashi N, Hada T, Nakanishi K: IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1- and Th2-cytokines and IL-8. Int Immunol 2004, 16:1733-1739
35. Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW: Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 1997, 185:1595-1604
36. Mantovani A, Gray PA, Van Damme J, Sozzani S: Macrophage-derived chemokine (MDC). J Leukoc Biol 2000, 68:400-404
37. Andrew DP, Chang MS, McNinch J, Wathen ST, Rihanek M, Tseng J, Spellberg JP, Elias CG 3rd. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998, 161:5027-5038
38. Galli G, Chantry D, Annunziato F, Romagnani P, Cosmi L, Lazzeri E, Manetti R, Maggi E, Gray PW, Romagnani S: Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 2000, 30:204-210
39. Golledge J, Tsao PS, Dalman RL, Norman PE: Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008, 118:2382-2392